Position in GOSS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$348,973
-$1,536,046 QoQ
Shares Held
2,114,988
+23.4% QoQ
Ownership
0.433%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#29
of 168 holders
Holding Since
Sep 2020
20 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in GOSS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MARSHALL WACE, LLP holds $3,014,740,742 across 267 Biotechnology names. GOSS ranks #227 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
543,897 | $270,169,956 | |
| 2 | INCY |
Incyte Corp
|
1,310,154 | $148,519,056 | |
| 3 | RPRX |
Royalty Pharma plc
|
2,450,669 | $137,409,009 | |
| 4 | SYRE |
Spyre Therapeutics, Inc.
|
991,693 | $88,042,503 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
259,799 | $78,207,292 | |
| 6 | TVTX |
Travere Therapeutics, Inc.
|
1,333,207 | $75,739,488 | |
| 7 | MANE |
Veradermics, Inc
|
585,560 | $71,988,746 | |
| 8 | DFTX |
Definium Therapeutics, Inc.
|
1,298,946 | $61,102,419 |
All Filings in GOSS
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $348,973 | 2,114,988 | Shares | Other | 2026-08-13 | |
| 2025-03-31 | $1,885,019 | 1,713,655 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $2,293,611 | 2,534,378 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $3,436,142 | 3,484,932 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $3,005,295 | 3,335,511 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $1,453,459 | 1,231,745 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $927,409 | 1,015,783 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $1,371,796 | 1,646,815 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $2,101,338 | 1,751,115 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $2,230,719 | 1,770,413 | Shares | Other | 2023-05-15 | |
| 2022-12-31 | $2,203,526 | 1,015,450 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $5,984,680 | 499,556 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $2,910,675 | 347,751 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $4,965,584 | 572,072 | Shares | Other | 2022-05-16 | |
| 2021-12-31 | $6,470,134 | 572,072 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $241,997 | 19,252 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $156,326 | 19,252 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $178,081 | 19,252 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $306,306 | 31,676 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $476,035 | 38,359 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||